Cite

HARVARD Citation

    Simões, E. et al. (2023). Immunogenicity and Safety of a Third COVID-19 BNT162b2 mRNA Vaccine Dose in 5- to 11-Year Olds. Journal of the Pediatric Infectious Diseases Society. 12 (4), pp. 234-238. [Online]. 
  
Back to record